BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11926306)

  • 1. Therapeutic effect of a pig-derived peptide antibiotic on porcine wound infections.
    Ceccarelli AV; Cole AM; Park AK; Tahk S; Yoshioka D; Ganz T
    Comp Med; 2001 Feb; 51(1):75-9. PubMed ID: 11926306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.
    Jacobsen F; Mohammadi-Tabrisi A; Hirsch T; Mittler D; Mygind PH; Sonksen CP; Raventos D; Kristensen HH; Gatermann S; Lehnhardt M; Daigeler A; Steinau HU; Steinstraesser L
    J Antimicrob Chemother; 2007 Mar; 59(3):493-8. PubMed ID: 17289767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of histone H1.2 in infected burn wounds.
    Jacobsen F; Baraniskin A; Mertens J; Mittler D; Mohammadi-Tabrisi A; Schubert S; Soltau M; Lehnhardt M; Behnke B; Gatermann S; Steinau HU; Steinstraesser L
    J Antimicrob Chemother; 2005 May; 55(5):735-41. PubMed ID: 15772144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antibacterial effect of cecropin B on pseudomonas aeruginosa infection of wounds in mice].
    Ren HT; Han CM; Zhang R; Xu ZJ; Meng ZQ; Weng HB; Niu BL
    Zhonghua Shao Shang Za Zhi; 2006 Dec; 22(6):445-7. PubMed ID: 17438692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel titanium wound chamber for the study of wound infections in pigs.
    Steinstraesser L; Vranckx JJ; Mohammadi-Tabrisi A; Jacobsen F; Mittler D; Lehnhardt M; Langer S; Kuhnen C; Gatermann S; Steinau HU; Eriksson E
    Comp Med; 2006 Aug; 56(4):279-85. PubMed ID: 16941955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infected wounds with the antimicrobial peptide D2A21.
    Chalekson CP; Neumeister MW; Jaynes J
    J Trauma; 2003 Apr; 54(4):770-4. PubMed ID: 12707542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer.
    Werthén M; Davoudi M; Sonesson A; Nitsche DP; Mörgelin M; Blom K; Schmidtchen A
    J Antimicrob Chemother; 2004 Oct; 54(4):772-9. PubMed ID: 15355938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of noncontact, nonthermal, low-frequency ultrasound on bacterial counts in experimental and chronic wounds.
    Serena T; Lee SK; Lam K; Attar P; Meneses P; Ennis W
    Ostomy Wound Manage; 2009 Jan; 55(1):22-30. PubMed ID: 19174586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic multiplex polymerase chain reaction assay for the identification of Pseudomonas aeruginosa from the skin biopsy specimens in burn wound infections and detection of antibiotic susceptibility.
    Mashouf RY; Zamani A; Farahani HS
    Saudi Med J; 2008 Aug; 29(8):1109-14. PubMed ID: 18690301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004-2006.
    Werckenthin C; Alesík E; Grobbel M; Lübke-Becker A; Schwarz S; Wieler LH; Wallmann J
    Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):412-22. PubMed ID: 17939456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production.
    Thorn RM; Nelson SM; Greenman J
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3217-24. PubMed ID: 17638701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
    J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo.
    Davis SC; Ricotti C; Cazzaniga A; Welsh E; Eaglstein WH; Mertz PM
    Wound Repair Regen; 2008; 16(1):23-9. PubMed ID: 18211576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
    Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
    J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
    Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
    Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds.
    Björn C; Noppa L; Näslund Salomonsson E; Johansson AL; Nilsson E; Mahlapuu M; Håkansson J
    Int J Antimicrob Agents; 2015 May; 45(5):519-24. PubMed ID: 25649371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
    Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
    Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.